I. Noordhoek

发表

R. Audisio, R. Ponzone, I. Rubio, 2021, Annals of Surgical Oncology.

Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy

H. Putter, Yi Zhang, C. V. D. van de Velde, 2020, Clinical Cancer Research.

Improving hormonal therapy: to extend, to intermit, or to readjust expectations?

C. Velde, E. Bastiaannet, I. Noordhoek, 2018 .

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.

J. Wesseling, E. Bastiaannet, J. Kroep, 2022, Journal of geriatric oncology.

European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery.

C. V. D. van de Velde, R. Audisio, W. Allum, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Incidence and clinical relevance of cage subsidence in anterior cervical discectomy and fusion: a systematic review

Marvyn T. Koning, W. Jacobs, C. Vleggeert-Lankamp, 2018, Acta Neurochirurgica.

Evaluation of bony fusion after anterior cervical discectomy: a systematic literature review

C. Vleggeert-Lankamp, I. Noordhoek, M. T. Koning, 2018, European Spine Journal.

Integrin regulation by tissue factor promotes cancer stemness and metastatic dissemination in breast cancer

P. Kuppen, H. Versteeg, W. Ruf, 2022, Oncogene.

Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer

J. Kroep, G. Liefers, I. Noordhoek, 2019, Breast Cancer Research and Treatment.

Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial

A. Jager, S. Linn, C. V. D. van de Velde, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials.

H. Putter, E. Rutgers, D. Rea, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.